Quantcast

Latest rheumatoid arthritis Stories

2013-12-31 08:22:46

Following the Successful Utilization of A3 Adenosine Receptor Biomarker in Can-Fite's Phase IIb Rheumatoid Arthritis Study PETACH TIKVA, Israel, Dec. 31, 2013 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today the following: The Company's subsidiary, OphthaliX Inc. (OTCQB: OPLI), will conduct a retrospective analysis...

2013-12-31 08:22:44

PETACH TIKVA, Israel, Dec. 31, 2013 /PRNewswire/ -- OphthaliX Inc. (OTCQB: OPLI), announced today that it will conduct a retrospective analysis of the Phase III Dry Eye Syndrome study data to determine if there is a correlation between the CF101 target, the A3 adenosine receptor, expression and patients' response to the drug. This analysis is based on recent positive data from a Phase IIb Rheumatoid Arthritis study of CF101 conducted by OphthaliX's parent company, Can-Fite BioPharma...

2013-12-30 23:24:22

Flexcin International, Inc. makers of USA made all natural health products creates new site for flagship brand, Flexcin with CM8®. Ft. Myers, Florida (PRWEB) December 30, 2013 - Flexcin International, Inc., the makers of all-natural health products including Flexcin with CM8®,a joint nutritional product that helps to alleviate the pain and stiffness associated with diseases like Arthritis and Fibromyalgia, launched a new website for Flexcin. The new website...

2013-12-30 00:20:21

PETACH TIKVA, Israel, Dec. 30, 2013 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine...

More Than 40 New Genetic Links To Rheumatoid Arthritis Discovered
2013-12-26 08:06:07

redOrbit Staff & Wire Reports - Your Universe Online An international team of scientists has uncovered more than 40 new genes, pathways and cell types linked to an increased risk of rheumatoid arthritis, according to research published Wednesday in the online edition of the journal Nature. The study, which according to BBC News science correspondent Pallab Ghosh, is the largest genetic study ever completed, involving nearly 30,000 rheumatoid arthritis (RA) patients and more than...

2013-12-23 11:12:18

New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Findings published in the American College of Rheumatology (ACR) journal Arthritis & Rheumatism, soon to be called Arthritis & Rheumatology, indicate the higher mortality rates persisted after adjusting for age, positive rheumatoid factor, positive antinuclear antibodies (ANA) and disease modifying anti-rheumatic...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.